These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 9890644

  • 1. Inhibition of copper-induced LDL oxidation by vitamin C is associated with decreased copper-binding to LDL and 2-oxo-histidine formation.
    Retsky KL, Chen K, Zeind J, Frei B.
    Free Radic Biol Med; 1999 Jan; 26(1-2):90-8. PubMed ID: 9890644
    [Abstract] [Full Text] [Related]

  • 2. Ascorbic acid oxidation product(s) protect human low density lipoprotein against atherogenic modification. Anti- rather than prooxidant activity of vitamin C in the presence of transition metal ions.
    Retsky KL, Freeman MW, Frei B.
    J Biol Chem; 1993 Jan 15; 268(2):1304-9. PubMed ID: 8419332
    [Abstract] [Full Text] [Related]

  • 3. Vitamin C prevents metal ion-dependent initiation and propagation of lipid peroxidation in human low-density lipoprotein.
    Retsky KL, Frei B.
    Biochim Biophys Acta; 1995 Aug 03; 1257(3):279-87. PubMed ID: 7647104
    [Abstract] [Full Text] [Related]

  • 4. Role of lipoprotein-copper complex in copper catalyzed-peroxidation of low-density lipoprotein.
    Kuzuya M, Yamada K, Hayashi T, Funaki C, Naito M, Asai K, Kuzuya F.
    Biochim Biophys Acta; 1992 Feb 12; 1123(3):334-41. PubMed ID: 1536873
    [Abstract] [Full Text] [Related]

  • 5. Copper ions promote peroxidation of low density lipoprotein lipid by binding to histidine residues of apolipoprotein B100, but they are reduced at other sites on LDL.
    Wagner P, Heinecke JW.
    Arterioscler Thromb Vasc Biol; 1997 Nov 12; 17(11):3338-46. PubMed ID: 9409331
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Thyroid hormone (T3) and its acetic derivative (TA3) protect low-density lipoproteins from oxidation by different mechanisms.
    Faure P, Oziol L, Artur Y, Chomard P.
    Biochimie; 2004 Jun 12; 86(6):411-8. PubMed ID: 15283976
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of low-density lipoprotein oxidation by carnosine histidine.
    Decker EA, Ivanov V, Zhu BZ, Frei B.
    J Agric Food Chem; 2001 Jan 12; 49(1):511-6. PubMed ID: 11305256
    [Abstract] [Full Text] [Related]

  • 9. Influence of natural antioxidants on in vitro lipoprotein oxidation.
    Dobreanu M, Módy E.
    Rom J Intern Med; 1997 Jan 12; 35(1-4):55-62. PubMed ID: 9562653
    [Abstract] [Full Text] [Related]

  • 10. The role of copper reduction by alpha-tocopherol in low-density lipoprotein oxidation.
    Proudfoot JM, Croft KD, Puddey IB, Beilin LJ.
    Free Radic Biol Med; 1997 Jan 12; 23(5):720-8. PubMed ID: 9296448
    [Abstract] [Full Text] [Related]

  • 11. The antioxidative effects of the isoflavan glabridin on endogenous constituents of LDL during its oxidation.
    Belinky PA, Aviram M, Fuhrman B, Rosenblat M, Vaya J.
    Atherosclerosis; 1998 Mar 12; 137(1):49-61. PubMed ID: 9568736
    [Abstract] [Full Text] [Related]

  • 12. Antioxidant and prooxidant effects of ascorbic acid, dehydroascorbic acid and flavonoids on LDL submitted to different degrees of oxidation.
    Otero P, Viana M, Herrera E, Bonet B.
    Free Radic Res; 1997 Dec 12; 27(6):619-26. PubMed ID: 9455697
    [Abstract] [Full Text] [Related]

  • 13. Ascorbic acid enhances 17 beta-estradiol-mediated inhibition of oxidized low density lipoprotein formation.
    Hwang J, Peterson H, Hodis HN, Choi B, Sevanian A.
    Atherosclerosis; 2000 Jun 12; 150(2):275-84. PubMed ID: 10856519
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of the oxidative modification of LDL by nitecapone.
    Pentikäinen MO, Lindstedt KA, Kovanen PT.
    Arterioscler Thromb Vasc Biol; 1995 Jun 12; 15(6):740-7. PubMed ID: 7773727
    [Abstract] [Full Text] [Related]

  • 15. Lycopene synergistically inhibits LDL oxidation in combination with vitamin E, glabridin, rosmarinic acid, carnosic acid, or garlic.
    Fuhrman B, Volkova N, Rosenblat M, Aviram M.
    Antioxid Redox Signal; 2000 Jun 12; 2(3):491-506. PubMed ID: 11229363
    [Abstract] [Full Text] [Related]

  • 16. Mechanism of the antioxidant to pro-oxidant switch in the behavior of dehydroascorbate during LDL oxidation by copper(II) ions.
    Horsley ET, Burkitt MJ, Jones CM, Patterson RA, Harris LK, Moss NJ, del Rio JD, Leake DS.
    Arch Biochem Biophys; 2007 Sep 15; 465(2):303-14. PubMed ID: 17689484
    [Abstract] [Full Text] [Related]

  • 17. Interactive effects of polyphenols, tocopherol and ascorbic acid on the Cu2+-mediated oxidative modification of human low density lipoproteins.
    Yeomans VC, Linseisen J, Wolfram G.
    Eur J Nutr; 2005 Oct 15; 44(7):422-8. PubMed ID: 15827683
    [Abstract] [Full Text] [Related]

  • 18. Tetradecylthioacetic acid inhibits the oxidative modification of low density lipoprotein and 8-hydroxydeoxyguanosine formation in vitro.
    Muna ZA, Doudin K, Songstad J, Ulvik RJ, Berge RK.
    Arterioscler Thromb Vasc Biol; 1997 Nov 15; 17(11):3255-62. PubMed ID: 9409320
    [Abstract] [Full Text] [Related]

  • 19. Cu(I) availability paradoxically antagonizes antioxidant consumption and lipid peroxidation during the initiation phase of copper-induced LDL oxidation.
    Bagnati M, Bordone R, Perugini C, Cau C, Albano E, Bellomo G.
    Biochem Biophys Res Commun; 1998 Dec 18; 253(2):235-40. PubMed ID: 9878521
    [Abstract] [Full Text] [Related]

  • 20. Vitamin C protects low-density lipoprotein from homocysteine-mediated oxidation.
    Alul RH, Wood M, Longo J, Marcotte AL, Campione AL, Moore MK, Lynch SM.
    Free Radic Biol Med; 2003 Apr 01; 34(7):881-91. PubMed ID: 12654477
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.